贷款飚千倍，分红仍过亿：SKG上市为哪般？

Core Viewpoint - The financial maneuvers of SKG, including a sudden dividend payout of nearly 200 million yuan and a dramatic increase in bank loans, raise questions about the company's long-term viability and intentions ahead of its IPO [2][4][7]. Financial Operations - In the first nine months of 2025, SKG declared dividends amounting to 199.4 million yuan, which is 1.87 times its net profit of 106 million yuan during the same period [2][4]. - The company's interest-bearing bank loans surged from 173,000 yuan at the end of 2022 to 180 million yuan by the end of the third quarter of 2025, marking an increase of over 1,000 times [2][4]. Shareholder Dynamics - SKG's founder Liu Jie and his wife control nearly 86% of the company, meaning approximately 171 million yuan from the recent dividend payout would flow into their accounts [7]. - This is not the first instance of significant dividend payouts during critical IPO phases, as the company previously distributed 155 million yuan and 160 million yuan in 2020 and 2021, respectively [7]. Market Position and Challenges - SKG's revenue growth has stagnated, with figures of 9.04 billion yuan, 10.46 billion yuan, 10.45 billion yuan, and 8.78 billion yuan from 2022 to the first three quarters of 2025, indicating a lack of momentum [15]. - The company's marketing expenditures have increased significantly, while R&D investment has decreased, raising concerns about its long-term innovation capabilities [16]. Competitive Landscape - The market is becoming increasingly competitive, with major players like Huawei and Xiaomi entering the smart health sector, posing a potential threat to SKG's market share [21]. - New brands are emerging with innovative marketing strategies, contrasting SKG's reliance on celebrity endorsements [21]. Future Outlook - SKG's third attempt at an IPO raises questions about whether it can overcome its current challenges and whether the listing will provide a sustainable solution or merely delay financial issues [20][24]. - The company's focus on marketing over product development may hinder its ability to adapt to changing market conditions and consumer expectations [24][28].